Pulse Biosciences Inc
Closed
SectorHealthcare
44.36 8.38
Overview
Share price change
24h
Min
41.35
Max
44.86
Income | -1.1M -19M |
|---|---|
Sales | 137K 401K |
EPS | -0.241 |
Profit margin | -4,633.666 |
Employees | 116 |
EBITDA | -1.7M -19M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | -1.23% downside |
Next Earnings | 4 Nov 2026 |
|---|
Market Cap | 1.1B 2.6B |
|---|---|
Previous open | 35.98 |
Previous close | 44.36 |
Pulse Biosciences Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Pulse Biosciences Inc Forecast
Price Target
By TipRanks
-1.23% downside
12 Months Forecast
Average 41 USD -1.23%
High 45 USD
Low 35 USD
Based on 3 Wall Street analysts offering 12 month price targets forPulse Biosciences Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.